Sapiens Reports Second Quarter 2025 Financial Results

Rhea-AI Summary

Sapiens International Corporation (NASDAQ: SPNS) reported its Q2 2025 financial results, showing mixed performance. Revenue increased by 3.5% to $141.6 million, while GAAP operating income declined by 23.2% to $16.8 million. The company's GAAP net income decreased to $14.2 million, with diluted EPS of $0.25, down 24.2% year-over-year.

During the quarter, Sapiens completed strategic acquisitions of Advantage Go and Candella to strengthen its P&C and Life insurance segments. The company continues to focus on platform innovation, cross-selling, cloud adoption, and global expansion of its Life & Annuities business, targeting accelerated growth in 2026.

Notably, Sapiens announced it has entered into a definitive agreement to be acquired by Advent, leading to the cancellation of its Q2 2025 earnings call.

Positive

• Strategic acquisitions of Advantage Go and Candella strengthen P&C and Life insurance segments
• Revenue growth of 3.5% year-over-year to $141.6 million
• Non-GAAP gross margin improved by 10 basis points to 45.8%
• Continued execution on platform innovation and cloud adoption strategy

Negative

• GAAP operating income declined 23.2% to $16.8 million
• GAAP net income decreased 23.6% to $14.2 million
• Operating margin contracted 410 basis points to 11.9%
• Diluted EPS dropped 24.2% to $0.25

Insights

Financial Analyst

Sapiens posted mixed Q2 results with modest revenue growth but concerning profit declines amid a pending acquisition by Advent.

Sapiens' Q2 2025 results present a mixed financial picture with modest top-line growth but concerning profitability metrics. Revenue increased by 3.5% year-over-year to $141.6 million, showing continued but slow expansion in their insurance software business. However, the company experienced significant compression in its profitability metrics, with GAAP operating income declining by 23.2% to $16.8 million and non-GAAP operating income falling by 7.1% to $23.1 million.

The operating margin deterioration is particularly noteworthy – GAAP operating margin contracted by 410 basis points to 11.9%, while non-GAAP operating margin declined by 190 basis points to 16.3%. This margin compression suggests rising costs are outpacing revenue growth, potentially due to integration expenses from the recently completed acquisitions of Advantage Go and Candella, which were highlighted as P&C and Life segment growth drivers.

Net income attributable to shareholders decreased by 23.6% on a GAAP basis to $14.2 million and by 8.2% on a non-GAAP basis to $19.3 million. Diluted EPS followed a similar pattern, declining 24.2% to $0.25 (GAAP) and 8.1% to $0.34 (non-GAAP).

Most significantly, the company disclosed it has entered into a definitive agreement to be acquired by Advent, explaining why management canceled their scheduled earnings call. This pending acquisition represents a major corporate development that supersedes the quarterly performance metrics and likely explains the limited forward guidance – merely stating they expect "accelerated growth in 2026" rather than providing specific financial targets for upcoming quarters.

ROCHELLE PARK, N.J., Aug. 13, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the second quarter ended June 30, 2025.

Summary Results for Second Quarter 2025 (USD in millions, except per share data)

	GAAP			Non-GAAP
	Q2 2025	Q2 2024	% Change	Q2 2025	Q2 2024	% Change
Revenue	$141.6	$136.8	3.5 %	$141.6	$136.8	3.5 %
Gross Profit	$61.9	$60.1	3.0 %	$64.8	$62.5	3.8 %
Gross Margin	43.7 %	43.9 %	-20 bps	45.8 %	45.7 %	10 bps
Operating Income	$16.8	$21.9	-23.2 %	$23.1	$24.8	-7.1 %
Operating Margin	11.9 %	16.0 %	-410 bps	16.3 %	18.2 %	-190 bps
Net Income (*)	$14.2	$18.6	-23.6 %	$19.3	$21.0	-8.2 %
Diluted EPS	$0.25	$0.33	-24.2 %	$0.34	$0.37	-8.1 %

(*) Attributable to Sapiens' shareholders

Roni Al-Dor, President and CEO of Sapiens, stated, "In the second quarter of 2025, we continued to execute on our strategic priorities, securing new deals and strengthening customer relationships across our Life, P&C, and Reinsurance segments.  Our insurance platform supports insurers in advancing digital transformation, improving operational efficiency, and adopting AI-driven innovation."

Mr. Al-Dor continued, "During the quarter, we completed the acquisitions of Advantage Go and Candella, acquisitions that strengthen our P&C and Life growth. We reiterate our priority to continue platform innovation, increase cross-selling, accelerate cloud adoption, and expand the Life & Annuities business globally, all of which will serve as catalysts to accelerated growth in 2026."   

Quarterly Results Conference Call

Following our announcement that Sapiens has entered into a definitive agreement to be acquired by Advent, Sapiens will forgo its Q2 2025 Earnings Call scheduled for today.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: non-GAAP revenue, ARR, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

 Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, and tax adjustments related to non-GAAP adjustments.

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Annual Recurring Revenue ("ARR") as the annualized value of our revenue from customer subscriptions, term licenses, maintenance, application maintenance, and cloud solutions, which may not be the same as the timing and amount of revenue recognized. The ARR run rate is equal to the product of (i) the sum of these revenues in our most recently completed fiscal quarter, multiplied by (ii) four.

The Company defines Adjusted EBITDA as net profit, adjusted to stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business.

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a global leader in intelligent insurance SaaS-based software solutions. With Sapiens' robust platform, customer-driven partnerships, and rich ecosystem, insurers are empowered to future-proof their organizations with operational excellence in a rapidly changing marketplace. Our SaaS-based Solutions help insurers harness the power of AI and advanced automation to support core solutions for property and casualty, workers' compensation, and life insurance, including reinsurance, financial & compliance, data & analytics, digital, and decision management. Sapiens boasts a longtime global presence, serving over 600 customers in more than 30 countries with its innovative offerings. Recognized by industry experts and selected for the Microsoft Top 100 Partner program, Sapiens is committed to partnering with our customers for their entire transformation journey and is continuously innovating to ensure their success. For more information visit sapiens or follow us on LinkedIn 

Investor and Media Contact
Yaffa Cohen-Ifrah
Chief Marketing Officer and Head of Investor Relations, Sapiens
Mobile: +1 917-533-4782
Email: Yaffa.cohen-ifrah@sapiens.com 

Investor Contact
Kimberly Rogers
Managing Director, Hayden IR
Phone: +1 541-904-5075
Email: kim@HaydenIR.com 

Forward Looking Statements

Certain matters discussed in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, and are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words "anticipate," "believe," "estimate," "expect," "may," "will," "plan" and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers' systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading "Risk Factors" in our most recent Annual Report on Form 20-F, which we filled with the SEC on March 31, 2022, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES                    CONDENSED CONSOLIDATED STATEMENT OF INCOME                    U.S. dollars in thousands (except per share amounts)
		Three months ended			Six months ended
		June 30,			June 30,
		2025	2024		2025		2024
		(unaudited)	(unaudited)		(unaudited)		(unaudited)
Revenue		141,602	136,800		277,707		271,049
Cost of revenue		79,711	76,696		155,156		153,385
Gross profit		61,891	60,104		122,551		117,664
Operating expenses:
Research and development, net		18,833	16,809		35,109		33,330
Selling, marketing, general and administrative		26,261	21,412		49,449		41,929
Total operating expenses		45,094	38,221		84,558		75,259
Operating income		16,797	21,883		37,993		42,405
Financial and other (income) expenses, net		(1,270)	(1,109)		(2,600)		(2,201)
Taxes on income		3,681	4,375		8,173		8,488
Net income		14,386	18,617		32,420		36,118
Attributable to non-controlling interest		154	-		252		141
Net income attributable to Sapiens' shareholders		14,232	18,617		32,168		35,977
Basic earnings per share		0.25	0.33		0.58		0.65
Diluted earnings per share		0.25	0.33		0.57		0.64
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)		55,897	55,797		55,892		55,771
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)		56,070	56,163		56,042		56,072

 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES  RECONCILIATION OF GAAP TO NON-GAAP RESULTS U.S. dollars in thousands (except per share amounts)
		Three months ended				Six months ended
		June 30,				June 30,
		2025		2024		2025		2024
		(unaudited)		(unaudited)		(unaudited)		(unaudited)
GAAP revenue		141,602		136,800		277,707			271,049
Valuation adjustment on acquired deferred revenue		-		-		-			-
Non-GAAP revenue		141,602		136,800		277,707			271,049
GAAP gross profit		61,891		60,104		122,551			117,664
Amortization of capitalized software		1,675		1,569		3,186			3,114
Amortization of other intangible assets		1,272		808		2,096			2,587
Non-GAAP gross profit		64,838		62,481		127,833			123,365
GAAP operating income		16,797		21,883		37,993			42,405
Gross profit adjustments		2,947		2,377		5,282			5,701
Capitalization of software development		(1,788)		(1,823)		(3,730)			(3,540)
Amortization of other intangible assets		2,094		1,223		3,654			2,456
Stock-based compensation		845		811		1,692			1,583
Acquisition-related costs *)		2,182		365		2,743			494
Non-GAAP operating income		23,077		24,836		47,634			49,099
GAAP net income attributable to Sapiens'   shareholders		14,232		18,617		32,168			35,977
Operating income adjustments		6,280		2,953		9,641			6,694
Taxes on income		(1,207)		(529)		(1,825)			(1,209)
Non-GAAP net income attributable to   Sapiens' shareholders		19,305		21,041		39,984			41,462

^(*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as tax, accounting and legal rendered until the acquisition date.

 

 

 

Adjusted EBITDA Calculation U.S. dollars in thousands
		Three months ended				Six months ended
		June 30,				June 30,
		2025		2024		2025		2024
GAAP operating profit		16,797		21,883		37,993		42,405
Non-GAAP adjustments:
Amortization of capitalized software		1,675		1,569		3,186		3,114
Amortization of other intangible assets		3,366		2,031		5,750		5,043
Capitalization of software development		(1,788)		(1,823)		(3,730)		(3,540)
Stock-based compensation		845		811		1,692		1,583
Compensation   related    to    acquisition   and acquisition-related costs		2,182		365		2,743		494
Non-GAAP operating profit		23,077		24,836		47,634		49,099
Depreciation		1,064		1,095		2,036		2,192
Adjusted EBITDA		24,141		25,931		49,670		51,291

 

 

 

Summary of NON-GAAP Financial Information  U.S. dollars in thousands (except per share amounts)
	Q2 2025		Q1 2025		Q4 2024		Q3 2024		Q2 2024
Revenues	141,602		136,105		134,305		137,025		136,800
Gross profit	64,838		62,995		62,692		62,809		62,481
Operating income	23,077		24,557		24,468		25,101		24,836
Adjusted EBITDA	24,141		25,529		25,359		26,389		25,931
Net income to Sapiens' shareholders	19,305		20,679		20,710		21,091		21,041
Diluted earnings per share	0.34		0.37		0.37		0.37		0.37

 

 

 

Annual Recurring Revenue ("ARR") U.S. dollars in thousands
		Three months ended
		June 30,
		2025				2024
Annual Recurring Revenue			199,646				168,593

 

 

 

Non-GAAP Revenues by Geographic Breakdown U.S. dollars in thousands
	Q2 2025		Q1 2025		Q4 2024		Q3 2024		Q2 2024
North America	59,782		56,871		56,753		55,755		57,918
Europe	70,095		67,480		65,624		69,281		66,072
Rest of the World	11,725		11,754		11,928		11,989		12,810
Total	141,602		136,105		134,305		137,025		136,800

 

 

 

Non-GAAP Revenue breakdown U.S. dollars in thousands
	Three months ended				Six months ended
	June 30,				June 30,
	2025		2024		2025		2024
Software products and re-occurring post-production services (*)	109,859		98,044		217,916		192,285
Pre-production implementation services (**)	31,743		38,756		59,791		78,764
Total Revenues	141,602		136,800		277,707		271,049

 

	Three months ended				Six months ended
	June 30,				June 30,
	2025		2024		2025		2024
Software products and re-occurring post-production services (*)	58,439		52,237		117,931		102,577
Pre-production implementation services (**)	6,399		10,244		9,902		20,788
Total Gross profit	64,838		62,481		127,833		123,365

 

	Three months ended				Six months ended
	June 30,				June 30,
	2025		2024		2025		2024
Software products and re-occurring post-production services (*)	53.2 %		53.3 %		54.1 %		53.3 %
Pre-production implementation services (**)	20.2 %		26.4 %		16.6 %		26.4 %
Gross Margin	45.8 %		45.7 %		46.0 %		45.5 %

^{(*) Software products and re-occurring post-production services include mainly subscription, term license, maintenance, application maintenance, cloud solutions and post-production services. This revenue stream is a mix of recurring and re-occurring in nature.}

^{(**) Pre-production implementation services include mainly implementation services before go-live, which are one-time in nature.}

 

 

Adjusted Free Cash-Flow U.S. dollars in thousands
	Q2 2025		Q1 2025		Q4 2024		Q3 2024		Q2 2024
Cash-flow from operating activities	1,873		25,353		42,109		13,083		8,545
Increase in capitalized software development costs	(1,788)		(1,942)		(1,759)		(1,834)		(1,823)
Capital expenditures	(1,003)		(366)		(419)		(1,125)		(666)
Free cash-flow	(918)		23,045		39,931		10,124		6,056
Cash payments attributed to acquisition-related  costs(*) (**)	626		-		1,238		124		134
Adjusted free cash-flow	(292)		23,045		41,169		10,248		6,190

^(*) Included in cash-flow from operating activities

^(**) Acquisition-related payments pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as completed or prospective third-party services, such as tax, accounting and legal rendered.

 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEET U.S. dollars in thousands
			June 30,		December 31,
			2025		2024
			(unaudited)		(unaudited)
ASSETS
CURRENT ASSETS
	Cash and cash equivalents		64,541		163,690
	Short-term bank deposit		10,000		52,500
	Trade receivables, net and unbilled receivables		134,949		99,603
	Other receivables and prepaid expenses		30,334		19,350
	Total current assets		239,824		335,143
LONG-TERM ASSETS
	Property and equipment, net		11,195		10,656
	Severance pay fund		3,065		3,208
	Goodwill and intangible assets, net		439,166		302,472
	Operating lease right-of-use assets		22,766		20,746
	Other long-term assets		23,628		19,486
	Total long-term assets		499,820		356,568
TOTAL ASSETS			739,644		691,711
LIABILITIES AND EQUITY
CURRENT LIABILITIES
	Trade payables		11,615		8,414
	Current maturities of Series B Debentures		19,804		19,796
	Accrued expenses and other liabilities		91,286		77,390
	Current maturities of operating lease liabilities		7,284		6,440
	Deferred revenue		44,697		37,543
	Total current liabilities		174,686		149,583
LONG-TERM LIABILITIES
	Series B Debentures, net of current maturities		-		19,792
	Deferred tax liabilities		13,710		6,899
	Other long-term liabilities		11,260		10,331
	Long-term operating lease liabilities		18,289		17,719
	Accrued severance pay		9,580		7,758
	Total long-term liabilities		52,839		62,499
REDEEMABLE NON-CONTROLLING INTEREST			13,809		-
EQUITY			498,310		479,629
TOTAL LIABILITIES AND EQUITY			739,644		691,711

 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES CONSOLIDATED STATEMENT OF CASH FLOW U.S. dollars in thousands
	For the six months ended June 30,
	2025		2024
	(unaudited)		(unaudited)
Cash flows from operating activities:
Net income	32,420		36,118
Reconciliation of net income to net cash provided by operating activities:
Depreciation of property and equipment	2,036		2,192
Amortization of intangible assets and capitalized software	8,936		8,157
Accretion of discount on Series B Debentures	12		22
Capital (gain) loss from sale of property and equipment	1		(9)
Stock-based compensation related to options issued to employees	1,692		1,583
Net changes in operating assets and liabilities, net of amount acquired:
Increase in trade receivables, net and unbilled receivables	(13,047)		(12,723)
Decrease in deferred tax liabilities, net	(1,874)		(1,428)
Decrease in other operating assets	1,011		3,445
Increase in trade payables	1,504		4,446
Decrease in other operating liabilities	(8,290)		(8,354)
Increase (decrease) in deferred revenues	1,966		(6,587)
Increase in accrued severance pay, net	859		171
Net cash provided by operating activities	27,226		27,033
Cash flows from investing activities:
Purchase of property and equipment	(1,399)		(1,146)
Proceeds from deposits	42,390		12,136
Proceeds from sale of property and equipment	27		14
Payments for business acquisitions, net of cash acquired	(106,189)		(375)
Capitalized software development costs	(3,730)		(3,540)
Net cash provided by (used in) investing activities	(68,901)		7,089
Cash flows from financing activities:
Proceeds from employee stock options exercised	-		98
Distribution of dividend	(37,037)		(15,635)
Repayment of Series B Debenture	(19,796)		(19,796)
Acquisition deferred payment	(455)		-
Acquisition of non-controlling interest	-		(4,131)
Net cash used in financing activities	(57,288)		(39,464)
Effect of exchange rate changes on cash and cash equivalents	(186)		1,272
Decrease in cash and cash equivalents	(99,149)		(4,070)
Cash and cash equivalents at the beginning of period	163,690		126,716
Cash and cash equivalents at the end of period	64,541		122,646

 

 

 

Debentures Covenants

As of June 30, 2025, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

Covenant 1 

• Target shareholders' equity (excluding non-controlling interest): above $120 million.
• Actual shareholders' equity (excluding non-controlling interest) equal to $498.3 million.

Covenant 2

• Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) below 65%.
• Actual ratio of net financial indebtedness to net capitalization equal to (12.25)%.

Covenant 3

• Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
• Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (0.54).

 

Logo: http://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg

 

View original content:https://www.prnewswire.com/news-releases/sapiens-reports-second-quarter-2025-financial-results-302528921.html

SOURCE Sapiens International Corporation

FAQ

What were Sapiens (SPNS) key financial results for Q2 2025?

Sapiens reported Q2 2025 revenue of $141.6 million (up 3.5%), GAAP operating income of $16.8 million (down 23.2%), and GAAP net income of $14.2 million with diluted EPS of $0.25 (down 24.2%).

Which companies did Sapiens acquire in Q2 2025?

Sapiens completed the acquisitions of Advantage Go and Candella to strengthen its P&C and Life insurance business segments.

What is happening with Sapiens' acquisition by Advent?

Sapiens announced it has entered into a definitive agreement to be acquired by Advent. As a result, the company canceled its Q2 2025 earnings call.

What are Sapiens' strategic priorities for growth?

Sapiens is focusing on platform innovation, increasing cross-selling, accelerating cloud adoption, and expanding the Life & Annuities business globally, targeting accelerated growth in 2026.

How did Sapiens' operating margins perform in Q2 2025?

Sapiens' GAAP operating margin declined by 410 basis points to 11.9%, while non-GAAP operating margin decreased by 190 basis points to 16.3%.